Latest Articles

Publication Date
Rosalind Franklin University Leader in Reproductive Immunology to Speak at the 2025 American Society of Reproductive Medicine Congress - The Malaysian Reserve

Rosalind Franklin University Leader in Reproductive Immunology to Speak at the 2025 American Society of Reproductive Medicine Congress The Malaysian Reserve

Published: Oct. 29, 2025, 7:22 p.m.
Rosalind Franklin University Leader in Reproductive Immunology to Speak at the 2025 American Society of Reproductive Medicine Congress - StreetInsider

Rosalind Franklin University Leader in Reproductive Immunology to Speak at the 2025 American Society of Reproductive Medicine Congress StreetInsider

Published: Oct. 29, 2025, 5:29 p.m.
Rosalind Franklin University Leader in Reproductive Immunology to Speak at the 2025 American Society of Reproductive Medicine Congress - Morningstar

Rosalind Franklin University Leader in Reproductive Immunology to Speak at the 2025 American Society of Reproductive Medicine Congress Morningstar

Published: Oct. 29, 2025, 5:27 p.m.
Aspira Women's Health Wins Laboratory Service Contract with University of Texas Medical Branch at Galveston - Lelezard

Aspira Women's Health Wins Laboratory Service Contract with University of Texas Medical Branch at Galveston Lelezard

Published: Oct. 29, 2025, 11:41 a.m.
Reframing Endometriosis: Interplay of NETs, Macrophages, and Lymphocytes at the Crossroads of Disease Progression, Infertility, and Malignant Transformation.

Endometriosis (ENDO) is a painful, chronic gynecological disease widely affecting women globally. While traditionally classified as a hormonal disorder, ENDO is now increasingly recognized as a multifaceted immune-mediated syndrome driven …

Published: Oct. 29, 2025, midnight
Gene Expression Profiling and Pathway Analysis of the Effect of Dienogest on Ovarian Endometriosis: A Comparative Study.

Endometriosis affects about 10% of reproductive-age women and can be managed through medical treatments, surgical intervention, or both. Approximately 40%-50% of patients experience recurrence within 5 years after surgery. Therefore, …

Published: Oct. 29, 2025, midnight
Multi-institutional study of mesonephric-like adenocarcinoma: its clinicopathological characteristics and histogenetic association with ectopic endometrium.

To explore the clinicopathological features and origin of mesonephric-like adenocarcinomas (MLAs), 83 cases diagnosed or suspected to be MLAs were collected from various institutions in Japan. We clearly classified 78 …

Published: Oct. 29, 2025, midnight
Bridging gaps in endometriosis care: a scoping review of complementary, alternative and/or integrative medicine for pain and quality of life.

Endometriosis is an inflammatory disorder characterized by ectopic endometrial-like tissue, affecting approximately 10% of women. It significantly impairs quality of life through symptoms such as dysmenorrhea, pelvic pain, and infertility. …

Published: Oct. 29, 2025, midnight
A Dual-Targeted Liposomal Nanosystem for Co-Delivery of Estrogen Receptor β Antagonist and Disulfiram for the Non-Hormonal Treatment of Endometriosis.

Endometriosis is an estrogen-dependent disease that severely affects the physical and mental health of women of childbearing age. Due to the significant side effects of traditional hormone therapies, non-hormonal treatment …

Published: Oct. 29, 2025, midnight
The effects of antioxidant supplementation on pain, oxidative stress markers, and clinical pregnancy rate in women with endometriosis: a systematic review and meta-analysis of randomized controlled trials.

Endometriosis is a chronic inflammatory disease characterized by pelvic pain and infertility, with oxidative stress playing a key role in its pathogenesis. Although antioxidant supplementation has been proposed as a …

Published: Oct. 29, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!